Panthera Biopartners, a UK based clinical trial Site Management Organization (SMO), has acquired Óbudai Egészségügyi Centrum Kft (OEC), an independent clinical research site network based in Hungary. The deal marks the major first step in Panthera’s European expansion strategy, bringing together two high-performing organizations to accelerate clinical trial delivery in the region. The acquisition follows Panthera’s investment from LDC, the private equity investor which is part of Lloyds Banki...